Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome

被引:118
作者
Charakida, Marietta [1 ]
Besler, Christian [2 ]
Batuca, Joana R. [3 ]
Sangle, Shirish [4 ]
Marques, Susanna [4 ]
Sousa, Miguel [4 ]
Wang, Guosu [1 ]
Tousoulis, Dimitris [5 ]
Alves, Jose Delgado [3 ]
Loukogeorgakis, Stavros P. [1 ]
Mackworth-Young, Charles [6 ]
D'Cruz, David [4 ]
Luscher, Thomas [2 ]
Landmesser, Ulf [2 ]
Deanfield, John E. [1 ]
机构
[1] UCL, Inst Child Hlth, Dept Vasc Physiol, London WC1N 1EH, England
[2] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland
[3] Univ Nova Lisboa, Dept Pharmacol, Lisbon, Portugal
[4] St Thomas Hosp, Rayne Inst, Lupus Res Unit, London SE1 7EH, England
[5] Univ Athens, Sch Med, Dept Cardiol, Hippokrat Hosp, GR-11527 Athens, Greece
[6] Charing Cross Hosp, Dept Rheumatol, London, England
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2009年 / 302卷 / 11期
关键词
HIGH-DENSITY-LIPOPROTEIN; INTIMA-MEDIA THICKNESS; AUTOIMMUNE RHEUMATIC-DISEASES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACCELERATED ATHEROSCLEROSIS; ANTIINFLAMMATORY PROPERTIES; PREMATURE ATHEROSCLEROSIS; SERUM PARAOXONASE; CAROTID ARTERIES; OXIDATIVE STRESS;
D O I
10.1001/jama.2009.1346
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Context Accelerated atherosclerosis has been described in antiphospholipid syndrome, but the vascular abnormalities and the underlying mechanisms remain unclear. Objectives To compare vascular structure and function in patients with positive antiphospholipid antibodies (aPL) with controls and to assess their relationship with paraoxonase activity. Design, Setting, and Participants A cross-sectional study of 77 women with positive antiphospholipid antibodies from a lupus outpatient clinic in London, England (90% of the eligible population) and 77 controls matched on frequency basis for age and cardiovascular risk factors between June 2006 and April 2009. Carotid intima media thickness (CIMT), flow-mediated dilatation, pulse wave velocity, and paraoxonase activity were measured in all patients. Anti-inflammatory and antioxidant properties of high-density lipoprotein (HDL) were examined. Main Outcome Measures CIMT, pulse wave velocity, flow-mediated dilatation, and paraoxonase. Results Women with aPL had greater CIMT and pulse wave velocity compared with controls (mean [SD], 0.75 [0.16] vs 0.64 [0.09] mm; 95% confidence interval [CI],-0.14 to-0.06; P<.001; and 9.2 [1.6] vs 8.5 [1.8] m/s; 95% CI,-1.14 to-0.06; P=.04) and lower flow-mediated dilatation (6.2% [4.1%] vs 9.6% [4.2%]; 95% CI, 2.02%-4.69%; P<.001). Paraoxonase activity was lower in women with aPL vs controls (median [interquartile range], 91.2 [64.3-105.1] vs 103.0 [80.5-111.5] mu mol p-nitrophenol/L/serum/min; 95% CI, 0.004-0.007; P=.005) and was inversely associated with CIMT and pulse wave velocity in women with aPL (standardized beta coefficient=-0.4 and-0.3, respectively; P<.05 for both), but not in the control group. High-density lipoprotein from women with aPL inhibited endothelial nitric oxide production in human aortic endothelial cells, in contrast with controls. The beneficial effects of HDL from women with aPL on vascular cell adhesion molecule 1 expression, superoxide production, and monocyte adhesion following activation of human aortic endothelial cells were largely blunted. Conclusions Compared with controls, women with aPL had greater functional and structural arterial abnormalities, which were associated with lower activity of paraoxonase. In patients with aPL, HDL reduced nitric oxide bioavailability and had impaired anti-inflammatory and antioxidant properties. JAMA. 2009; 302(11): 1210-1217
引用
收藏
页码:1210 / 1217
页数:8
相关论文
共 39 条
[1]
Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model [J].
Alves, JD ;
Mason, LJ ;
Ames, PRJ ;
Chen, PP ;
Rauch, J ;
Levine, JS ;
Subang, R ;
Isenberg, DA .
RHEUMATOLOGY, 2005, 44 (10) :1238-1244
[2]
Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome [J].
Alves, JD ;
Kumar, S ;
Isenberg, DA .
RHEUMATOLOGY, 2003, 42 (07) :893-899
[3]
Antibodies against β2-glycoprotein I complexed with an oxidised lipoprotein relate to intima thickening of carotid arteries in primary antiphospholipid syndrome [J].
Ames, P. R. J. ;
Alves, J. Delgado ;
Lopez, L. R. ;
Gentile, F. ;
Margarita, A. ;
Pizzella, L. ;
Batuca, J. ;
Scenna, G. ;
Brancaccio, V. ;
Matsuura, E. .
CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2006, 13 (01) :1-9
[4]
Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data [J].
Ames, PRJ ;
Margarita, A ;
Sokoll, KB ;
Weston, M ;
Brancaccio, V .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) :315-317
[5]
Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies [J].
Ames, PRJ ;
Margarita, A ;
Alves, JD ;
Tommasino, C ;
Iannaccone, L ;
Brancaccio, V .
LUPUS, 2002, 11 (04) :208-214
[6]
The paradox of dysfunctional high-density lipoprotein [J].
Ansell, Benjamin J. ;
Fonarow, Gregg C. ;
Fogelman, Alan M. .
CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (04) :427-434
[7]
Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment [J].
Ansell, BJ ;
Navab, M ;
Hama, S ;
Kamranpour, N ;
Fonarow, G ;
Hough, G ;
Rahmani, S ;
Mottahedeh, R ;
Dave, R ;
Reddy, ST ;
Fogelman, AM .
CIRCULATION, 2003, 108 (22) :2751-2756
[8]
Aviram Michael, 2008, V477, P259, DOI 10.1007/978-1-60327-517-0_20
[9]
Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus [J].
Batuca, J. R. ;
Ames, P. R. J. ;
Amaral, M. ;
Favas, C. ;
Isenberg, D. A. ;
Alves, J. Delgado .
RHEUMATOLOGY, 2009, 48 (01) :26-31
[10]
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk [J].
Bhattacharyya, Tamali ;
Nicholls, Stephen J. ;
Topol, Eric J. ;
Zhang, Renliang ;
Yang, Xia ;
Schmitt, David ;
Fu, Xiaoming ;
Shao, Mingyuan ;
Brennan, Danielle M. ;
Ellis, Stephen G. ;
Brennan, Marie-Luise ;
Allayee, Hooman ;
Lusis, Aldons J. ;
Hazen, Stanley L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (11) :1265-1276